One of the world’s first Omicron-specific Covid-19 variant vaccines is to be trialled in Greater Manchester. The booster vaccine study will start in Salford this week, and will see around 100 people receive a first or second booster dose.
The study is one of the first globally to assess the effectiveness of a fourth Covid-19 jab, starting in Salford on April 9, continuing until April 11. Half of the volunteers will receive a Moderna Omicron variant vaccine and the other half will be vaccinated with the commonly used standard Moderna Covid-19 vaccine (Spikevax).
Trial organisers are calling on people to come forward to take part in the study. It is open to people who are yet to receive their first booster dose - those who have received just two primary doses.
